Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Biochem Pharmacol. 2011 Oct 15;82(8):931-42. doi: 10.1016/j.bcp.2011.06.039. Epub 2011 Jul 7.

Research update: Alpha7 nicotinic acetylcholine receptor mechanisms in Alzheimer's disease.

Author information

  • 1School of Life and Health Sciences, Aston University, Birmingham, UK.

Abstract

Aberrant amyloid-β peptide (Aβ) accumulation along with altered expression and function of nicotinic acetylcholine receptors (nAChRs) stand prominently in the etiology of Alzheimer's disease (AD). Since the discovery that Aβ is bound to α7 nAChRs under many experimental settings, including post-mortem AD brain, much effort has been expended to understand the implications of this interaction in the disease milieu. This research update will review the current literature on the α7 nAChR-Aβ interaction in vitro and in vivo, the functional consequences of this interaction from sub-cellular to cognitive levels, and discuss the implications these relationships might have for AD therapies.

Copyright © 2011 Elsevier Inc. All rights reserved.

PMID:
21763291
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk